World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
24029
World Ranking
17089
National Ranking
562

Overview

Xavier Puéchal is affiliated with Université Paris Cité in France and has a significant body of research primarily in the field of Medicine, with a strong emphasis on Pulmonary and Respiratory Medicine, Rheumatology, Genetics, Physiology, and Immunology. Their scientific work involves key topics such as vasculitis and related conditions, coagulation processes, sarcoidosis, otitis media, urticaria, eosinophilic disorders, and Whipple's disease.

The research outputs by Xavier Puéchal include multiple notable publications spanning high-impact journals. Some recent papers are:

  • Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis, 2020, New England Journal of Medicine
  • Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, 2020, Annals of Internal Medicine
  • Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study, 2020, Arthritis & Rheumatology
  • French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides), 2020, Orphanet Journal of Rare Diseases
  • Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis, 2020, Clinical Journal of the American Society of Nephrology

Collaborative work features several frequent coauthors, including:

  • Benjamin Terrier
  • Loïc Guillevin
  • Luc Mouthon
  • Alexandre Karras
  • Pascal Cohen

Xavier Puéchal's publications often appear in recurring venues such as:

  • La Revue de Médecine Interne
  • Lara D. Veeken
  • Annals of the Rheumatic Diseases
  • Revue du Rhumatisme
  • Seminars in Arthritis and Rheumatism

The scientific investigation centers notably on vasculitis and related autoimmune conditions. The integration of genetics and immunology in their studies supports a multidisciplinary approach to complex systemic diseases. Research contributions also extend to coagulation pathways and disorders related to eosinophilic syndromes, reflecting a broad spectrum of clinical and biological inquiry.

Best Publications

  • Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

    Loïc Guillevin;Christian Pagnoux;Alexandre Karras;Chahera Khouatra

  • Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

    Cloé Comarmond;Christian Pagnoux;Mehdi Khellaf;Jean-François Cordier

  • Whipple's disease.

    Florence Fenollar;Xavier Puéchal;Didier Raoult

  • Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome

    Régis Sablé-Fourtassou;Pascal Cohen;Alfred Mahr;Christian Pagnoux

  • Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

    Michael Walsh;Peter A Merkel;Chen-Au Peh;Wladimir M Szpirt

  • A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.

    Gary S. Hoffman;Maria C. Cid;David B. Hellmann;Loic Guillevin

  • Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.

    Christian Pagnoux;Alfred Mahr;Mohamed A. Hamidou;Jean-Jacques Boffa

  • Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

    Xavier Mariette;Philippe Ravaud;Serge Steinfeld;Gabriel Baron

  • Treatment of Primary Sjögren Syndrome With Rituximab: A Randomized Trial

    Valérie Devauchelle-Pensec;Xavier Mariette;Sandrine Jousse-Joulin;Jean-Marie Berthelot

  • Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.

    Camillo Ribi;Pascal Cohen;Christian Pagnoux;Alfred Mahr

  • Vasculitides associated with malignancies: analysis of sixty patients.

    Olivier Fain;Mohamed Hamidou;Patrice Cacoub;Bertrand Godeau

  • Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

    Dominique Salmon-Céron;Florence Tubach;Olivier Lortholary;Olivier Chosidow

  • Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome: The JOQUER Randomized Clinical Trial

    Jacques-Eric Gottenberg;Philippe Ravaud;Xavier Puéchal;Véronique Le Guern

  • Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.

    Loïc Guillevin;Pascal Cohen;Alfred Mahr;Jean-Pierre Arène

  • Eprodisate for the treatment of renal disease in AA amyloidosis.

    Laura M. Dember;Philip N. Hawkins;Bouke P.C. Hazenberg;Peter D. Gorevic

  • Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

    Pierre Charles;Benjamin Terrier;Élodie Perrodeau;Pascal Cohen

  • Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial

    Raphaèle Seror;Gabriel Baron;Eric Hachulla;Michel Debandt

  • EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

    Neil Basu;Richard Watts;Ingeborg Bajema;Bo Baslund

  • Long-term Outcomes of 118 Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss Syndrome) Enrolled in Two Prospective Trials

    Maxime Samson;Xavier Puéchal;Hervé Devilliers;Camillo Ribi

  • Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients.

    Xavier Puéchal;Gerard Said;Pascal Hilliquin;Joel Coste

Frequent Co-Authors

Loïc Guillevin
Loïc Guillevin Université Paris Cité
Luc Mouthon
Luc Mouthon Université Paris Cité
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Jean Sibilia
Jean Sibilia University of Strasbourg
Eric Hachulla
Eric Hachulla University of Lille
Philippe Ravaud
Philippe Ravaud Université Paris Cité
Olivier Fain
Olivier Fain Université Paris Cité
Maxime Dougados
Maxime Dougados Hôpital Cochin
Alfred Mahr
Alfred Mahr Université Paris Cité
Laure Gossec
Laure Gossec Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in pursuing careers in healthcare but not ready to commit to a traditional Medicine program, a variety of related online degrees offer flexible, cost-effective alternatives. Many students begin their path with affordable medical billing and coding programs, which provide a gateway into the administrative side of healthcare and can be completed quickly online.

Nursing is another popular option. Prospective nurses can explore what is the cheapest online college for nursing? to find programs that fit their budget and career goals. For those seeking advanced practice roles, it’s wise to consider the cheapest online acute care nurse practitioner programs, which prepare graduates for specialized patient care positions.

For nurses aiming for leadership, academia, or research, various online phd programs nursing are available at accessible price points, enabling working professionals to advance without leaving their current roles. These online healthcare degrees can pave the way for dynamic and rewarding career pathways beyond medical school.

Best Scientists Citing Xavier Puéchal

Trending Scientists